{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:11:44Z","timestamp":1792120304938,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:00:00Z","timestamp":1795046400000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["U01HL134812"],"award-info":[{"award-number":["U01HL134812"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RC2DK120535"],"award-info":[{"award-number":["RC2DK120535"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24DK092760"],"award-info":[{"award-number":["R24DK092760"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54DK110805"],"award-info":[{"award-number":["U54DK110805"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024726","name":"Howard Hughes Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007886","name":"Dana-Farber Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.exphem.2025.105264","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:19:51Z","timestamp":1757859591000},"page":"105264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9000-7366","authenticated-orcid":false,"given":"Ashlee J.","family":"Conway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolulope O.","family":"Rosanwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2197-7334","authenticated-orcid":false,"given":"Samuel","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda T.","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3620-2950","authenticated-orcid":false,"given":"R. Grant","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3126-8432","authenticated-orcid":false,"given":"William","family":"Marion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosra","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4320-2852","authenticated-orcid":false,"given":"Nathaniel K.","family":"Mullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3243-4439","authenticated-orcid":false,"given":"Michael","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha M.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1104-6843","authenticated-orcid":false,"given":"Matthew M.","family":"Heeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1599-9908","authenticated-orcid":false,"given":"Thorsten M.","family":"Schlaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8534-5515","authenticated-orcid":false,"given":"Manoj T.","family":"Duraisingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Brugnara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1249-563X","authenticated-orcid":false,"given":"Trista E.","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6346-5919","authenticated-orcid":false,"given":"George Q.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2025.105264_bib0001","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2025.105264_bib0002","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s11739-019-02160-x","article-title":"Sickle cell disease: a review for the internist","volume":"14","author":"Pinto","year":"2019","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.exphem.2025.105264_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.exphem.2025.105264_bib0004","first-page":"381","article-title":"Genetic and epigenetic mechanisms of \u03b2-globin gene switching","volume":"83","author":"Iarovaia","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.exphem.2025.105264_bib0005","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cell.2018.03.016","article-title":"Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2025.105264_bib0006","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1126\/science.1165409","article-title":"Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A","volume":"322","author":"Sankaran","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.exphem.2025.105264_bib0007","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1073\/pnas.1807405115","article-title":"Simultaneous polymerization and adhesion under hypoxia in sickle cell disease","volume":"115","author":"Papageorgiou","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2025.105264_bib0008","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ymthe.2024.01.015","article-title":"A new frontier: FDA approvals for gene therapy in sickle cell disease","volume":"32","author":"Leonard","year":"2024","journal-title":"Mol Ther"},{"key":"10.1016\/j.exphem.2025.105264_bib0009","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.944204","article-title":"Editorial: first regulatory approvals for CRISPR-Cas9 therapeutic gene editing for sickle cell disease and transfusion-dependent \u03b2-thalassemia","volume":"30","author":"Parums","year":"2024","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.exphem.2025.105264_bib0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/ejh.12447","article-title":"Hematopoietic stem cell transplantation for sickle cell disease: state of the science","volume":"94","author":"Talano","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.exphem.2025.105264_bib0011","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41573-018-0003-2","article-title":"Therapeutic strategies for sickle cell disease: towards a multi-agent approach","volume":"18","author":"Telen","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.exphem.2025.105264_bib0012","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1517\/14740338.2015.1088827","article-title":"Hydroxyurea therapy for sickle cell anemia","volume":"14","author":"McGann","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.exphem.2025.105264_bib0013","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2025.105264_bib0014","doi-asserted-by":"crossref","DOI":"10.1177\/20406207241292508","article-title":"Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease: final results from the phase II SOLACE-adults study","volume":"15","author":"Kanter","year":"2024","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.exphem.2025.105264_bib0015","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.3324\/haematol.2019.229211","article-title":"Comparing the two leading erythroid lines BEL-A and HUDEP-2","volume":"105","author":"Daniels","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.105264_bib0016","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-4939-7428-3_17","article-title":"Growing and genetically manipulating human umbilical cord blood-derived erythroid progenitor (HUDEP) cell lines","volume":"1698","author":"Vinjamur","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.exphem.2025.105264_bib0017","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.omtm.2018.03.007","article-title":"Serum-free erythroid differentiation for efficient genetic modification and high-level adult hemoglobin production","volume":"9","author":"Uchida","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.exphem.2025.105264_bib0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nbt1047","article-title":"Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells","volume":"23","author":"Giarratana","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.exphem.2025.105264_bib0019","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1537-2995.2008.01828.x","article-title":"In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells","volume":"48","author":"Baek","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.exphem.2025.105264_bib0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41467-017-00448-0","article-title":"Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin","volume":"8","author":"Huang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2025.105264_bib0021","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/nbt1245","article-title":"Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells","volume":"24","author":"Miharada","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.exphem.2025.105264_bib0022","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1182\/blood.V97.10.3313","article-title":"Fatal sickle cell crisis after granulocyte colony-stimulating factor administration","volume":"97","author":"Adler","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105264_bib0023","first-page":"532","article-title":"Hemoglobinopathies: clinical manifestations, diagnosis, and treatment","volume":"108","author":"Kohne","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.exphem.2025.105264_bib0024","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/1535370216636726","article-title":"Minireview: Genetic basis of heterogeneity and severity in sickle cell disease","volume":"241","author":"Habara","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.exphem.2025.105264_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.05.004","article-title":"Sickle cell disease: clinical presentation and management of a global health challenge","volume":"37","author":"Houwing","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.exphem.2025.105264_bib0026","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-148-12-200806170-00221","article-title":"Systematic review: hydroxyurea for the treatment of adults with sickle cell disease","volume":"148","author":"Lanzkron","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.exphem.2025.105264_bib0027","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.4081\/hr.2016.6678","article-title":"Study on hydroxyurea response in hemoglobinopathies patients using genetic markers and liquid erythroid cultures","volume":"8","author":"Sclafani","year":"2016","journal-title":"Hematol Rep"},{"key":"10.1016\/j.exphem.2025.105264_bib0028","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40169-016-0092-7","article-title":"Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce \u03b3-globin expression: implications for new therapeutic approaches of sickle cell disease","volume":"5","author":"Pule","year":"2016","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.exphem.2025.105264_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012743","article-title":"Gingival fibroblasts as a promising source of induced pluripotent stem cells","volume":"5","author":"Egusa","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2025.105264_bib0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.scr.2018.09.011","article-title":"Generation of integration-free iPS cell lines from three sickle cell disease patients from the state of Bahia","volume":"33","author":"Martins","year":"2018","journal-title":"Brazil. Stem Cell Res."},{"key":"10.1016\/j.exphem.2025.105264_bib0031","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood-2009-07-234690","article-title":"Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells","volume":"115","author":"Grigoriadis","year":"2010","journal-title":"Blood"},{"issue":"148","key":"10.1016\/j.exphem.2025.105264_bib0032","doi-asserted-by":"crossref","DOI":"10.3791\/59823","article-title":"Hemogenic endothelium differentiation from human pluripotent stem cells in a feeder- and xeno-free defined condition","author":"Ohta","year":"2019","journal-title":"J Vis Exp"},{"key":"10.1016\/j.exphem.2025.105264_bib0033","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MOH.0b013e3283476129","article-title":"Red blood cells from induced pluripotent stem cells: hurdles and developments","volume":"18","author":"Mazurier","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2025.105264_bib0034","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/stem.1136","article-title":"Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusion","volume":"30","author":"Zeuner","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2025.105264_bib0035","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3324\/haematol.2010.023556","article-title":"Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine","volume":"95","author":"Lapillonne","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.105264_bib0036","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1182\/blood-2009-11-252650","article-title":"Globin phenotype of erythroid cells derived from human induced pluripotent stem cells","volume":"115","author":"Chang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105264_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025761","article-title":"Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells","volume":"6","author":"Chang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2025.105264_bib0038","doi-asserted-by":"crossref","first-page":"eaah5645","DOI":"10.1126\/scitranslmed.aah5645","article-title":"Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors","volume":"9","author":"Doulatov","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.exphem.2025.105264_bib0039","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nbt.3070","article-title":"A comparison of non-integrating reprogramming methods","volume":"33","author":"Schlaeger","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.exphem.2025.105264_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-981-13-9589-5_2","article-title":"Cellular iron metabolism and regulation","volume":"1173","author":"Gao","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.exphem.2025.105264_bib0041","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1182\/bloodadvances.2018018820","article-title":"Characterization of Tfrc-mutant mice with microcytic phenotypes","volume":"2","author":"Conway","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2025.105264_bib0042","first-page":"2010","article-title":"Labeling cytoskeletal F-actin with rhodamine phalloidin or fluorescein phalloidin for imaging","author":"Chazotte","year":"2010","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.exphem.2025.105264_bib0043","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/s41467-021-21886-x","article-title":"Plasmodium vivax infection compromises reticulocyte stability","volume":"12","author":"Clark","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2025.105264_bib0044","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/bj2370265","article-title":"Sickle cell membranes and oxidative damage","volume":"237","author":"Rice-Evans","year":"1986","journal-title":"Biochem J"},{"key":"10.1016\/j.exphem.2025.105264_bib0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fmolb.2019.00142","article-title":"Hemorheological alterations and oxidative damage in sickle cell anemia","volume":"6","author":"Caprari","year":"2019","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.exphem.2025.105264_bib0046","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI112144","article-title":"Sickle erythrocyte adherence to vascular endothelium. Morphologic correlates and the requirement for divalent cations and collagen-binding plasma proteins","volume":"76","author":"Mohandas","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2025.105264_bib0047","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1182\/blood.V87.11.4879.bloodjournal87114879","article-title":"Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin","volume":"87","author":"Hillery","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105264_bib0048","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mrgentox.2007.09.005","article-title":"DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea","volume":"649","author":"Friedrisch","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.exphem.2025.105264_bib0049","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1182\/blood-2017-05-783233","article-title":"Increased risk of leukemia among sickle cell disease patients in California","volume":"130","author":"Brunson","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105264_bib0050","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156060","article-title":"Clonal hematopoiesis in sickle cell disease","volume":"132","author":"Liggett","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2025.105264_bib0051","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1111\/bjh.16693","article-title":"Gene expression of HIF-1\u03b1 and VEGF in response to hypoxia in sickle cell anaemia: influence of hydroxycarbamide","volume":"190","author":"Pedrosa","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2025.105264_bib0052","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2141.2010.08109.x","article-title":"Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension","volume":"149","author":"Zorca","year":"2010","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.exphem.2025.105264_bib0053","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/S0022-2275(20)30036-5","article-title":"Abnormal phospholipid molecular species of erythrocytes in sickle cell anemia","volume":"38","author":"Connor","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.exphem.2025.105264_bib0054","first-page":"813","article-title":"Reduced cholesterol levels in African-American adults with sickle cell disease","volume":"95","author":"Shores","year":"2003","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.exphem.2025.105264_bib0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/0148607107031004263","article-title":"Abumrad N. Defects in postabsorptive plasma homeostasis of fatty acids in sickle cell disease","volume":"31","author":"Buchowski","year":"2007","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.exphem.2025.105264_bib0056","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41586-019-1244-x","article-title":"Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation","volume":"571","author":"Wilkinson","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.105264_bib0057","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2025.105264_bib0058","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/mt.2016.148","article-title":"CRISPR\/Cas9-mediated correction of the sickle mutation in human CD34+ cells","volume":"24","author":"Hoban","year":"2016","journal-title":"Mol Ther"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25005533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25005533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:34:26Z","timestamp":1773048866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X25005533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":58,"alternative-id":["S0301472X25005533"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2025.105264","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2025.105264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Experimental Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105264"}}